BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Naurex Inc. 

1801 Maple Avenue
Suite 4300
Evanston  Illinois  60201  U.S.A.
Phone: 317-250-3276 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
FDA Grants Fast Track Designation To Naurex Inc.'s Rapid-Acting Novel Antidepressant GLYX-13 3/3/2014 10:09:09 AM    More...
Naurex Inc. To Present At Cowen and Company 34th Annual Health Care Conference 2/27/2014 6:43:43 AM    More...
Naurex Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/10/2014 6:26:23 AM    More...
Naurex Inc. Names Dr. Norbert G. Riedel President And Chief Executive Officer 1/8/2014 7:11:09 AM    More...
Naurex Inc. Announces Issuance of New Patent for Novel Antidepressant GLYX-13 7/30/2013 9:01:57 AM    More...
Naurex Inc. Announces Initiation of Phase I Trial for Second-Generation Novel Antidepressant Agent NRX-1074 6/4/2013 9:17:45 AM    More...
Naurex Inc. Completes $38 Million Series B Financing 12/17/2012 7:41:09 AM    More...
Naurex Inc. Release: Phase II Data Presented at ACNP 2012 Shows Novel Antidepressant GLYX-13 Significantly Reduces Depression Scores Within Hours 12/6/2012 9:35:32 AM    More...
Naurex Inc.'s Novel Antidepressant GLYX-13 Recognized as One of Windhover Information Inc.'s 2011 Top 10 Neuroscience Projects to Watch 11/7/2011 12:29:19 PM    More...
Naurex Inc. Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression 6/22/2011 8:30:46 AM    More...
12

//-->